Latest Compliance News

INOVIQ Limited confirms no undisclosed price-sensitive information amid recent share price surge, attributing the move to external research spotlighting upcoming EXO-OC ovarian cancer test data.

HITIQ Limited secured a Federal Court order extending the quotation period for its HIQOA listed options on the ASX, resolving a regulatory timing issue and validating the delayed admission.

Resources & Energy Group (ASX:REZ) has locked in a binding term sheet with Rembrandt Mining to kickstart gold production at its Maranoa deposit, preserving full ownership while shifting capital risk to Rembrandt and capturing enhanced profit shares at higher gold prices.

Neurizon Therapeutics has secured a critical five-year supply agreement with Elanco Animal Health for GMP-grade monepantel, underpinning the commercialisation readiness of its lead ALS drug candidate NUZ-001.

AIC Mines has returned strong drilling results from the Jolly shoot at its Jericho copper deposit, reinforcing the deposit’s potential as the first mining target and underpinning the ramp-up of production at nearby Eloise.

WhiteHawk Limited has forged a strategic alliance with Perth-based Adisyn Services to enhance cyber risk management and compliance solutions tailored for the defence sector, focusing on AUKUS programs and supply chain security.

Atlas Arteria’s Independent Directors maintain a unanimous rejection of IFM’s $5.10 per security takeover bid, citing undervaluation and insufficient control premium. The company reiterates its 2026 distribution guidance and confirms active asset sale discussions, including Chicago Skyway.

CLINUVEL Pharmaceuticals has lodged its Form 20-F with the U.S. SEC, seeking to elevate its American Depository Receipt program to a Nasdaq-listed American Depository Share, aiming to boost visibility and liquidity without raising capital.

Firebird Metals has placed all critical equipment orders for its Perth-based Australian Demonstration Plant, triggering the first ARENA grant payment and setting the stage for a pivotal 90-day fabrication phase. The project remains on track for early Q4 2026 equipment delivery, with imminent lithium manganese rich cathode results expected from its China pilot plant.

Centuria Capital Group unveils a vertically integrated AI and data centre strategy through its partnership with ResetData, aiming to capture surging sovereign AI demand amid global supply constraints.

InteliCare (ASX:ICR) is hitting a commercial inflection point, backed by a landmark $8.8 million contract with mecwacare and a growing pipeline across aged care sectors. Its AI-powered platform promises measurable improvements in care outcomes and operational efficiency.

LTR Pharma has confirmed it disclosed a binding US commercialisation agreement for ROXUS promptly after signing, responding to ASX scrutiny over pre-announcement trading activity.